{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:14:58Z","timestamp":1780103698030,"version":"3.54.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jns.2026.125907","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:05:49Z","timestamp":1776233149000},"page":"125907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prevalence and attribution of polyneuropathy in p.V142I (V122I) hereditary transthyretin amyloidosis"],"prefix":"10.1016","volume":"486","author":[{"given":"John E.","family":"Dvorak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Khella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Drachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Row","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Pieretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansie","family":"Mathelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafic","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2026.125907_bb0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-022-02359-w","article-title":"Clinical and genetic profile of patients enrolled in the transthyretin amyloidosis outcomes survey (THAOS): 14-year update","volume":"17","author":"Dispenzieri","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2026.125907_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13023-024-03198-7","article-title":"Treatment characteristics of patients with hereditary transthyretin amyloidosis: a cohort study","volume":"19","author":"Qarni","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2026.125907_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11886-024-02172-w","article-title":"Transthyretin cardiac amyloidosis: current and emerging therapies","volume":"27","author":"Patel","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.jns.2026.125907_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African\u2013Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.jns.2026.125907_bb0025","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1038\/s41598-021-91113-6","article-title":"Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry","volume":"11","author":"Parker","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jns.2026.125907_bb0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.28414","article-title":"Peripheral nervous system involvement of hereditary transthyretin amyloidosis in the United States: a multi-center perspective","volume":"72","author":"Desai","year":"2025","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.jns.2026.125907_bb0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cardfail.2019.07.031","article-title":"Identifying mixed phenotype: evaluating the presence of polyneuropathy in patients with hereditary transthyretin-mediated amyloidosis with cardiomyopathy","volume":"25","author":"Grogan","year":"2019","journal-title":"J. Card. Fail."},{"issue":"19","key":"10.1016\/j.jns.2026.125907_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207158","article-title":"Phenotypes associated with the Val122Ile, Leu58His, and late-onset Val30Met variants in patients with hereditary transthyretin amyloidosis","volume":"100","author":"Zampino","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2026.125907_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13506129.2022.2046557","article-title":"Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays","volume":"29","author":"Kaku","year":"2022","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.jns.2026.125907_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13506129.2023.2227322","article-title":"Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study","volume":"30","author":"Albenque","year":"2023","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.jns.2026.125907_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2026.125907_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000001160","article-title":"Incidence of polyneuropathy in Utrecht, the Netherlands","volume":"84","author":"Visser","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125907_bb0065","article-title":"National diabetes statistics report","author":"CDC","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2026.125907_bb0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinbiochem.2022.10.007","article-title":"Age- and ethnicity-related reference intervals for serum vitamin b12","volume":"111","author":"Sobczy\u0144ska-Malefora","year":"2023","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.jns.2026.125907_bb0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.28026","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: recommendations from a panel of experts","volume":"69","author":"Karam","year":"2024","journal-title":"Muscle Nerve"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:07:55Z","timestamp":1778702875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S0022510X26001899"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125907","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and attribution of polyneuropathy in p.V142I (V122I) hereditary transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125907"}}